These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Structural Complexity and Plasticity of Signaling Regulation at the Melanocortin-4 Receptor. Kleinau G; Heyder NA; Tao YX; Scheerer P Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32785054 [TBL] [Abstract][Full Text] [Related]
4. Differential Signaling Profiles of MC4R Mutations with Three Different Ligands. Paisdzior S; Dimitriou IM; Schöpe PC; Annibale P; Scheerer P; Krude H; Lohse MJ; Biebermann H; Kühnen P Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059383 [TBL] [Abstract][Full Text] [Related]
5. Agonist-dependent internalization of the human melanocortin-4 receptors in human embryonic kidney 293 cells. Gao Z; Lei D; Welch J; Le K; Lin J; Leng S; Duhl D J Pharmacol Exp Ther; 2003 Dec; 307(3):870-7. PubMed ID: 14534363 [TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of feline melanocortin 4 receptor and melanocortin 2 receptor accessory protein 2. Habara M; Mori N; Okada Y; Kawasumi K; Nakao N; Tanaka Y; Arai T; Yamamoto I Gen Comp Endocrinol; 2018 May; 261():31-39. PubMed ID: 29360464 [TBL] [Abstract][Full Text] [Related]
7. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands. Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118 [TBL] [Abstract][Full Text] [Related]
8. Constitutive activity of the melanocortin-4 receptor is maintained by its N-terminal domain and plays a role in energy homeostasis in humans. Srinivasan S; Lubrano-Berthelier C; Govaerts C; Picard F; Santiago P; Conklin BR; Vaisse C J Clin Invest; 2004 Oct; 114(8):1158-64. PubMed ID: 15489963 [TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist. Xiang Z; Litherland SA; Sorensen NB; Proneth B; Wood MS; Shaw AM; Millard WJ; Haskell-Luevano C Biochemistry; 2006 Jun; 45(23):7277-88. PubMed ID: 16752916 [TBL] [Abstract][Full Text] [Related]
10. Structure activity studies of the melanocortin-4 receptor by in vitro mutagenesis: identification of agouti-related protein (AGRP), melanocortin agonist and synthetic peptide antagonist interaction determinants. Haskell-Luevano C; Cone RD; Monck EK; Wan YP Biochemistry; 2001 May; 40(20):6164-79. PubMed ID: 11352754 [TBL] [Abstract][Full Text] [Related]
11. SHU9119 and MBP10 are biased ligands at the human melanocortin-4 receptor. Dai HC; Ji RL; Tao YX Biochem Pharmacol; 2024 Oct; 228():116325. PubMed ID: 38815629 [TBL] [Abstract][Full Text] [Related]
14. Mapping the binding site of melanocortin 4 receptor agonists: a hydrophobic pocket formed by I3.28(125), I3.32(129), and I7.42(291) is critical for receptor activation. Hogan K; Peluso S; Gould S; Parsons I; Ryan D; Wu L; Visiers I J Med Chem; 2006 Feb; 49(3):911-22. PubMed ID: 16451057 [TBL] [Abstract][Full Text] [Related]
15. Molecular determinants of human melanocortin-4 receptor responsible for antagonist SHU9119 selective activity. Yang Y; Chen M; Lai Y; Gantz I; Georgeson KE; Harmon CM J Biol Chem; 2002 Jun; 277(23):20328-35. PubMed ID: 11912210 [TBL] [Abstract][Full Text] [Related]
16. Characterization of MC4R Regulation of the Kir7.1 Channel Using the Tl Litt MJ; Cone RD; Ghamari-Langroudi M Methods Mol Biol; 2018; 1684():211-222. PubMed ID: 29058194 [TBL] [Abstract][Full Text] [Related]
17. Insights into the Allosteric Mechanism of Setmelanotide (RM-493) as a Potent and First-in-Class Melanocortin-4 Receptor (MC4R) Agonist To Treat Rare Genetic Disorders of Obesity through an in Silico Approach. Falls BA; Zhang Y ACS Chem Neurosci; 2019 Mar; 10(3):1055-1065. PubMed ID: 30048591 [TBL] [Abstract][Full Text] [Related]
18. Structure elucidation of a human melanocortin-4 receptor specific orthosteric nanobody agonist. Fontaine T; Busch A; Laeremans T; De Cesco S; Liang YL; Jaakola VP; Sands Z; Triest S; Masiulis S; Dekeyzer L; Samyn N; Loeys N; Perneel L; Debaere M; Martini M; Vantieghem C; Virmani R; Skieterska K; Staelens S; Barroco R; Van Roy M; Menet C Nat Commun; 2024 Oct; 15(1):7029. PubMed ID: 39353917 [TBL] [Abstract][Full Text] [Related]
19. Structural insight into the MC4R conformational changes via different agonist-mediated receptor signaling. Yang Y; Chen M; Dimmitt R; Harmon CM Biochemistry; 2014 Nov; 53(45):7086-92. PubMed ID: 25347793 [TBL] [Abstract][Full Text] [Related]